
Sumitomo Pharma Co Ltd
TSE:4506

Intrinsic Value
The intrinsic value of one
Sumitomo Pharma Co Ltd
stock under the Base Case scenario is
806.36
JPY.
Compared to the current market price of 680 JPY,
Sumitomo Pharma Co Ltd
is
Undervalued by 16%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Sumitomo Pharma Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Sumitomo Pharma Co Ltd
Balance Sheet Decomposition
Sumitomo Pharma Co Ltd
Current Assets | 333.7B |
Cash & Short-Term Investments | 102B |
Receivables | 97.3B |
Other Current Assets | 134.4B |
Non-Current Assets | 518.4B |
Long-Term Investments | 38.2B |
PP&E | 52.6B |
Intangibles | 403.3B |
Other Non-Current Assets | 24.4B |
Free Cash Flow Analysis
Sumitomo Pharma Co Ltd
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Sumitomo Pharma Co Ltd
Revenue
|
372.7B
JPY
|
Cost of Revenue
|
-147.2B
JPY
|
Gross Profit
|
225.6B
JPY
|
Operating Expenses
|
-449.4B
JPY
|
Operating Income
|
-223.9B
JPY
|
Other Expenses
|
47.8B
JPY
|
Net Income
|
-176B
JPY
|
Profitability Score
Profitability Due Diligence
Sumitomo Pharma Co Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Score
Sumitomo Pharma Co Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Sumitomo Pharma Co Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.

Score
Sumitomo Pharma Co Ltd's solvency score is 29/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Sumitomo Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for
Sumitomo Pharma Co Ltd
is 644.06 JPY
with a low forecast of 424.2 JPY and a high forecast of 945 JPY.
Dividends
Current shareholder yield for Sumitomo Pharma Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Sumitomo Pharma Co Ltd
stock under the Base Case scenario is
806.36
JPY.
Compared to the current market price of 680 JPY,
Sumitomo Pharma Co Ltd
is
Undervalued by 16%.